“AliveCor, a startup that builds heart-monitoring sensors for smartphones, is building sensors for another mobile device: The Apple Watch,” Mark Bergen reports for Re/code.
“AliveCor is also putting out a new app replete with speech-recognition features that, paired with the watch sensor, the startup hopes will replace the cumbersome, expensive devices for patients with pressing heart conditions,” Bergen reports. “And the company claims it’s releasing each with the seal of approval from the Food and Drug Administration at a time when other medical devices and bio-tech firms have hit regulatory blockades with the agency (or simply run afoul of it).”
Bergen reports, “‘AliveCor sits on the other side of the FDA line,’ CEO Vic Gundotra told Re/code. ‘We are not a fitness product. This is not a toy. We’re talking about people’s lives.'”
Read more in the full article here.
AliveCor Apple Watch ultrasonic ECG heart monitoring band planned for 2016 launch – October 16, 2015
AliveCor launches new iOS-only app to auto detect atrial fibrillation in an ECG recording – September 29, 2014